RxDoctor Payments Data

Vincent Dilella, DO

Family Medicine · Dunedin, FLNPI 1760471502

Payments from drug & device makers

$710in general payments, 2019–2025

Across 26 payments — averaging $27.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$135
  • Cardinal Health 200 LLC$114
  • Smith+Nephew$112
  • Boston Scientific$90
  • Novo Nordisk$63
  • UCB, Inc.$57
  • plus $139 from 6 others

What the payments were for

  • Food & beverage$710100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$710 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$302,817
Medicare patients
908
Services billed
3,237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban1,537$464,765
MavyretGlecaprevir/Pibrentasvir11$153,378
XifaxanRifaximin87$137,611
BiktarvyBictegrav/Emtricit/Tenofov Ala28$112,374
SantylCollagenase Clostridium Hist.130$108,045
XareltoRivaroxaban343$106,376
NuplazidPimavanserin Tartrate42$97,780
IngrezzaValbenazine Tosylate20$74,510
Trelegy ElliptaFluticasone/Umeclidin/Vilanter107$74,018
GenvoyaElviteg/Cob/Emtri/Tenof Alafen16$67,286
JanuviaSitagliptin Phosphate184$65,685
Invega SustennaPaliperidone Palmitate18$60,499
ErtapenemErtapenem Sodium126$55,523
ProcritEpoetin Alfa81$54,134
MyrbetriqMirabegron186$51,339

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieMavyret, Linzess$135$170,73440 claims
Smith+NephewSantyl$112$108,045130 claims
Astellas Pharma US IncMyrbetriq$24$51,339186 claims
Novo NordiskOzempic$63$23,99712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Dunedin

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →